Moderna, Inc. (0QF.F)

EUR 24.0

(-2.24%)

Long Term Debt Summary of Moderna, Inc.

Moderna, Inc.'s latest annual long term debt in 2023 was 1.21 Billion USD , up 21.31% from previous year.
Moderna, Inc.'s latest quarterly long term debt in 2024 Q2 was 1.24 Billion USD , down 0.0% from previous quarter.
Moderna, Inc. reported annual long term debt of 1 Billion USD in 2022, up 42.41% from previous year.
Moderna, Inc. reported annual long term debt of 705 Million USD in 2021, up 240.1% from previous year.
Moderna, Inc. reported quarterly long term debt of 1.24 Billion USD for 2024 Q2, down 0.0% from previous quarter.
Moderna, Inc. reported quarterly long term debt of 927 Million USD for 2023 Q1, down -7.67% from previous quarter.

Annual Long Term Debt Chart of Moderna, Inc. (2023 - 2016)

Historical Annual Long Term Debt of Moderna, Inc. (2023 - 2016)

Year	Long Term Debt	Long Term Debt Growth
2023	1.21 Billion USD	21.31%
2022	1 Billion USD	42.41%
2021	705 Million USD	240.1%
2020	207.29 Million USD	56.61%
2019	132.36 Million USD	295.25%
2018	33.48 Million USD	113.48%
2017	15.68 Million USD	25.5%
2016	12.5 Million USD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	1.21 Billion USD	0.0%
2024 Q2	1.24 Billion USD	0.0%
2023 Q1	927 Million USD	-7.67%
2023 Q3	1.27 Billion USD	34.32%
2023 Q2	947 Million USD	2.16%
2023 FY	1.21 Billion USD	21.31%
2023 Q4	1.21 Billion USD	-4.25%
2022 Q4	1 Billion USD	0.3%
2022 Q3	1 Billion USD	37.5%
2022 Q2	728 Million USD	-1.75%
2022 FY	1 Billion USD	42.41%
2022 Q1	741 Million USD	5.11%
2021 Q1	234 Million USD	12.88%
2021 Q3	343 Million USD	-20.79%
2021 Q4	705 Million USD	105.54%
2021 FY	705 Million USD	240.1%
2021 Q2	433 Million USD	85.04%
2020 Q4	207.29 Million USD	-0.13%
2020 Q2	167.77 Million USD	13.48%
2020 Q1	147.84 Million USD	11.7%
2020 FY	207.29 Million USD	56.61%
2020 Q3	207.56 Million USD	23.72%
2019 Q2	33.58 Million USD	0.61%
2019 FY	132.36 Million USD	295.25%
2019 Q4	132.36 Million USD	291.6%
2019 Q3	33.8 Million USD	0.63%
2019 Q1	33.38 Million USD	-0.31%
2018 Q3	26.89 Million USD	0.0%
2018 FY	33.48 Million USD	113.48%
2018 Q4	33.48 Million USD	24.53%
2017 Q4	15.68 Million USD	0.0%
2017 FY	15.68 Million USD	25.5%
2016 FY	12.5 Million USD	0.0%

Peer Long Term Debt Comparison of Moderna, Inc.

Name	Long Term Debt	Long Term Debt Difference
BioNTech SE	191 Million EUR	-537.696%
CureVac N.V.	36.81 Million EUR	-3208.075%
Biotest Aktiengesellschaft	377.3 Million EUR	-222.82%
Biotest Aktiengesellschaft	377.3 Million EUR	-222.82%
BRAIN Biotech AG	25.19 Million EUR	-4734.676%
Formycon AG	7.81 Million EUR	-15485.413%
Heidelberg Pharma AG	70.4 Thousand EUR	-1729841.625%
Medigene AG	2.03 Million EUR	-59723.183%